Breaking Down The People's Insurance Company (Group) of China Limited Financial Health: Key Insights for Investors

Curious whether The People's Insurance Company of China Limited (1339.HK) is a bargain or a risk? Start here: the insurer posted 581.53 billion CNY in revenue for 2024 and a trailing twelve-month revenue of 608.43 billion CNY (TTM growth 13.04%), while Q1 2025 net income jumped to 12.849 billion CNY with EPS rising to 0.29 CNY; profitability metrics show a 18.05% ROE and a 7.8% net profit margin in 2024, returns including a 3.13% ROA and 10.34% ROIC, and valuation looks attractive with a trailing P/E near 5.40-5.70, P/B 0.84 and market cap of 396.59 billion HKD-yet balance-sheet strength is clear too, with total assets of 1.94 trillion CNY, total liabilities of 1.52 trillion CNY, cash and short-term investments of 427.07 billion CNY, a current ratio of 2.75 and debt-to-equity around 0.38; read on for a data-driven breakdown of liquidity, leverage, valuation, risk exposures (claims, market volatility, regulatory shifts) and growth levers from the silver economy to digital expansion that investors need to weigh.

The People's Insurance Company of China Limited (1339.HK) - Revenue Analysis

The People's Insurance Company of China Limited (1339.HK) has shown solid top-line expansion across FY2024 and the trailing twelve months (TTM) to June 30, 2025, supported by rising investment returns and core insurance premium growth. Key figures and trend indicators are summarized below.

• FY2024 revenue: 581.53 billion CNY (up 10.70% from 525.33 billion CNY in FY2023).
• TTM revenue (ending 30 Jun 2025): 608.43 billion CNY (TTM YoY growth: 13.04%).
• Q1 2025 net income: 12.849 billion CNY vs Q1 2024: 8.963 billion CNY.
• Q1 2025 EPS: 0.29 CNY vs Q1 2024 EPS: 0.20 CNY.
• Revenue per employee: ~3.92 million CNY, indicating operational leverage and workforce efficiency.

• Momentum: The 13.04% TTM growth signals accelerating revenue capture versus FY2024's 10.70% increase.
• Profitability lift: Q1 2025 net income and EPS improvements point to better underwriting and/or investment outcomes in the recent quarter.
• Efficiency: Revenue per employee (~3.92M CNY) suggests effective scaling of the business relative to workforce size.

Further investor context and shareholder activity can be found here: Exploring The People's Insurance Company (Group) of China Limited Investor Profile: Who's Buying and Why?

The People's Insurance Company of China Limited (1339.HK) - Profitability Metrics

The People's Insurance Company of China Limited (1339.HK) showed marked improvement across core profitability measures in 2024, driven by higher underwriting gains, investment income recovery and tighter expense control.

• Net profit margin: improved from 4.5% (2023) to 7.8% (2024)
• EBIT margin: significant improvement reflecting efficient cost management (2023: 7.1% → 2024: 11.3%)
• Return on equity (ROE): 18.05% (2024)
• Return on assets (ROA): 3.13% (2024)
• Return on invested capital (ROIC): 10.34% (2024)
• Earnings per share (TTM): 1.13 CNY; P/E ratio: 5.70 (implying relative undervaluation vs. peers)

• Drivers: underwriting margin expansion, recovered investment returns, and disciplined expense management.
• Investor implications: elevated ROE/ROIC and low P/E point to attractive return profile relative to price, but watch investment portfolio volatility and regulatory changes.
• Valuation lens: with EPS at 1.13 CNY and P/E of 5.70, market pricing reflects a conservative outlook despite improved fundamentals.

Further context on the company's background and structural position can be found here: The People's Insurance Company (Group) of China Limited: History, Ownership, Mission, How It Works & Makes Money

The People's Insurance Company of China Limited (1339.HK) - Debt vs. Equity Structure

• Debt-to-equity trend: declined from 52.4% to 37.4% over five years, signaling reduced financial leverage and deleveraging progress.
• Current debt-to-equity ratio: 0.38 (38%), consistent with a conservative capital structure.
• Total liabilities (Sep 2025): 1.52 trillion CNY; total assets (Sep 2025): 1.94 trillion CNY - implying an equity base of ~420 billion CNY and a solid asset-liability scale.
• Operating cash flow coverage of debt: 63.6% - operating cash flow covers a meaningful portion of outstanding debt.
• Interest coverage (EBIT / interest): 51.2x - interest payments are very well covered by operating earnings.
• Equity ratio: stable over the period, reflecting consistent capital management and retained earnings support.

• Investor implications: lower leverage reduces solvency risk and volatility in return-on-equity; strong cash and EBIT coverage significantly mitigates refinancing and interest-rate risk.
• Risk considerations: while leverage is conservative, continued monitoring of liability composition (insurance reserves, debt maturities) is essential for assessing liquidity under stress.
• Where to read more on corporate intent and capital management philosophy: Mission Statement, Vision, & Core Values (2026) of The People's Insurance Company (Group) of China Limited.

The People's Insurance Company of China Limited (1339.HK) - Liquidity and Solvency

• Current ratio: 2.75 - indicates ability to cover current liabilities nearly 2.8 times with current assets.
• Quick ratio: 2.46 - reflects sufficient immediately liquid assets (excluding inventories) to settle near-term obligations.
• Interest coverage ratio: 59.13 - shows a very strong cushion to meet interest payments from operating earnings.

• Cash & short-term investments: 427.07 billion CNY - nearly equal to total equity, underscoring high cash reserves.
• Asset-to-liability coverage: total assets (1.94T) exceed liabilities (1.52T) by ~420.0 billion CNY, supporting solvency.

The People's Insurance Company of China Limited (1339.HK) - Valuation Analysis

• Trailing P/E: 5.40 - low absolute earnings multiple versus peers and the sector.
• Forward P/E: 5.48 - market expects modest changes in near-term earnings; still low.
• P/B: 0.84 - stock trades below book value, indicating potential margin of safety or underlying balance-sheet value underappreciation.
• EV/EBITDA: 6.44 - reasonable operating earnings multiple, signaling fair valuation for cash-operating performance.
• EV/FCF: 6.20 - efficient capital utilization and attractive free-cash-flow yield implied by a low multiple.
• PEG: 0.40 - suggests valuation is low relative to earnings growth expectations (price/earnings-to-growth).

The People's Insurance Company of China Limited (1339.HK) - Risk Factors

• Catastrophe and large-scale claims exposure - Recent large property fires and industrial accidents in Greater China and Hong Kong have resulted in single-event claims running into the hundreds of millions of HKD/RMB for some insurers, underlining the accumulation risk in property and commercial lines. A single catastrophic event could represent a multi-percentage-point hit to annual underwriting profit for a major insurer.
• Market volatility and low interest-rate environment - Investment returns are a core earnings component for insurers. For example, major peers reported year-on-year net profit declines of double-digit percentages in low-yield years; an illustrative peer saw net profit fall by roughly 30-50% in a recent tough market year. Prolonged low rates compress net investment margins and raise reinvestment risk.
• Regulatory and policy changes - The insurance sector in China and Hong Kong has seen regulatory tightening on capital adequacy, product suitability, and asset allocation. Changes to solvency regimes or distribution rules can increase compliance costs and require higher capital buffers, reducing return on equity in the near term.
• Macroeconomic slowdown and consumer spending contraction - GDP deceleration or falling disposable income can reduce demand for both life and non-life products. Historically, a 1-2% decline in GDP growth has correlated with lower premium growth rates (single-digit percentage point drops) in retail lines.
• Currency and translation risk - Cross-border operations and foreign asset holdings expose earnings to RMB/HKD/USD movements. A 5-10% currency move can materially alter reported investment returns and equity on a translated basis for conglomerate insurers.
• Competitive pressures - Intense competition from domestic giants (e.g., larger integrated insurers and bancassurance partners) and nimble InsurTech entrants pressures pricing, distribution margins, and new-business persistency, potentially reducing market share and compressing combined ratios.

• Combined ratio and segmental loss ratios (P&C vs. life) - rising trends indicate underwriting stress.
• Net investment yield and duration exposure - shows sensitivity to rates and market drawdowns.
• Solvency and capital adequacy ratios - regulatory buffers and available capital for shocks.
• Expense and acquisition cost trends - reflect distribution competitiveness and profitability of new business.
• Large loss frequency and reserve development - signals adequacy of technical provisions.

The People's Insurance Company of China Limited (1339.HK) - Growth Opportunities

• Silver economy: China's 65+ population is large and ageing - estimates place the 65+ share around 14% (2023) with continued growth - creating sustained demand for retirement, long-term care and annuity products.
• Health & senior care: Strong sector momentum - e.g., Ping An reported a 39.8% increase in new business value in health and senior-care segments - signals sizable addressable opportunities for tailored insurance and service bundles.
• High-dividend banking equity allocation: Tactical allocation to high-dividend domestic banking stocks (typical yields ~4-6% historically for major Chinese banks) can enhance portfolio yield versus low-yield fixed income.
• Underpenetrated geographies: Lower insurance density in interior provinces and selected Hong Kong segments implies clear upside from targeted distribution expansion and product localization.
• Digital & insurtech: Automation, AI-driven underwriting and digital distribution can reduce expense ratios, improve persistency and scale agency/ bancassurance channels.
• Partnerships & M&A: Strategic alliances with health providers, senior-care operators, fintechs and regional insurers can accelerate customer acquisition and service breadth.

• Priority execution levers: develop modular senior-care product suites (annuities, LTC riders, chronic-care plans); allocate a measured portion of invested assets to stable, high-dividend bank equities; pilot digital-first distribution in underpenetrated provinces; pursue partnerships with reputable healthcare and senior-service operators.
• Risk & capital considerations: these initiatives require prudent capital management, reinsurance structuring for longevity and morbidity risk, and robust ALM to keep solvency ratios (RBC/solvency margin) resilient while pursuing growth.